Search Results - "Ahlskog, J."

Refine Results
  1. 1

    Aerobic Exercise: Evidence for a Direct Brain Effect to Slow Parkinson Disease Progression by Ahlskog, J. Eric

    Published in Mayo Clinic proceedings (01-03-2018)
    “…No medications are proven to slow the progression of Parkinson disease (PD). Of special concern with longer-standing PD is cognitive decline, as well as motor…”
    Get full text
    Journal Article
  2. 2

    Does vigorous exercise have a neuroprotective effect in Parkinson disease? by AHLSKOG, J. Eric

    Published in Neurology (19-07-2011)
    “…Parkinson disease (PD) is progressive, with dementia and medication-refractory motor problems common reasons for late-stage nursing-home placement. Increasing…”
    Get full text
    Journal Article
  3. 3

    Parkinson's disease progression is multifaceted: Evidence for the underlying benchmarks by Ahlskog, J. Eric

    Published in Parkinsonism & related disorders (01-04-2024)
    “…Long-term Parkinson's disease (PD) progression is not a homogeneous process and manifests in diverse ways over the lifetime. Recognition of progression…”
    Get full text
    Journal Article
  4. 4

    Time Trends in the Incidence of Parkinson Disease by Savica, Rodolfo, Grossardt, Brandon R, Bower, James H, Ahlskog, J Eric, Rocca, Walter A

    Published in JAMA neurology (01-08-2016)
    “…Changes over time in the incidence of parkinsonism and Parkinson disease (PD) remain uncertain. To investigate secular trends (period effects) and birth cohort…”
    Get more information
    Journal Article
  5. 5

    Levodopa, homocysteine and Parkinson's disease: What's the problem? by Ahlskog, J. Eric

    Published in Parkinsonism & related disorders (01-04-2023)
    “…Elevated circulating homocysteine levels have been associated with cognitive impairment and cardio-cerebro-vascular events. Levodopa treatment of Parkinson's…”
    Get full text
    Journal Article
  6. 6

    Physical Exercise as a Preventive or Disease-Modifying Treatment of Dementia and Brain Aging by Ahlskog, J. Eric, PhD, MD, Geda, Yonas E., MD, MSc, Graff-Radford, Neill R., MBBCh, FRCP, Petersen, Ronald C., PhD, MD

    Published in Mayo Clinic proceedings (01-09-2011)
    “…A rapidly growing literature strongly suggests that exercise, specifically aerobic exercise, may attenuate cognitive impairment and reduce dementia risk. We…”
    Get full text
    Journal Article
  7. 7

    Common Myths and Misconceptions That Sidetrack Parkinson Disease Treatment, to the Detriment of Patients by Ahlskog, J. Eric

    Published in Mayo Clinic proceedings (01-10-2020)
    “…Parkinson disease symptoms become apparent when there has been substantial loss of brain dopamine. That is the consequence of the slow progression of the Lewy…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Medical records documentation of constipation preceding Parkinson disease: A case-control study by SAVICA, R, CARLIN, J. M, GROSSARDT, B. R, BOWER, J. H, AHLSKOG, J. E, MARAGANORE, D. M, BHARUCHA, A. E, ROCCA, W. A

    Published in Neurology (24-11-2009)
    “…Parkinson disease (PD) may affect the autonomic nervous system and may cause constipation; however, few studies have explored constipation preceding the motor…”
    Get full text
    Journal Article
  10. 10

    Hyperglycemic chorea/ballism ascertained over 15 years at a referral medical center by Ryan, Conor, Ahlskog, J. Eric, Savica, Rodolfo

    Published in Parkinsonism & related disorders (01-03-2018)
    “…To describe chorea/ballism triggered by a hyperglycemic event. We used the electronic records system at Mayo Clinic–Rochester to identify patients diagnosed…”
    Get full text
    Journal Article
  11. 11

    Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause by ROCCA, W. A, BOWER, J. H, MARAGANORE, D. M, AHLSKOG, J. E, GROSSARDT, B. R, DE ANDRADE, M, MELTON, L. J

    Published in Neurology (11-09-2007)
    “…There is increasing laboratory evidence for a neuroprotective effect of estrogen; however, the clinical and epidemiologic evidence remains limited and…”
    Get full text
    Journal Article
  12. 12

    Beating a dead horse : Dopamine and Parkinson disease by AHLSKOG, J. Eric

    Published in Neurology (23-10-2007)
    “…Our collective thinking about Parkinson disease (PD) has been heavily influenced by the dramatic response to dopamine replacement therapy. For progress to…”
    Get full text
    Journal Article
  13. 13

    High School Football and Risk of Neurodegeneration: A Community-Based Study by Savica, Rodolfo, MD, MSc, Parisi, Joseph E., MD, Wold, Lester E., MD, Josephs, Keith A., MD, MST, MSc, Ahlskog, J. Eric, PhD, MD

    Published in Mayo Clinic proceedings (01-04-2012)
    “…Abstract Objective To assess whether high school football played between 1946 and 1956, when headgear was less protective than today, was associated with…”
    Get full text
    Journal Article
  14. 14

    Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism by Savica, Rodolfo, Grossardt, Brandon R, Bower, James H, Ahlskog, J Eric, Rocca, Walter A

    Published in JAMA neurology (01-07-2013)
    “…The frequency and distribution of synucleinopathies and tauopathies manifesting with parkinsonism in the general population are poorly understood, thus…”
    Get more information
    Journal Article
  15. 15
  16. 16

    My Treatment Approach to Multiple System Atrophy by Coon, Elizabeth A., Ahlskog, J. Eric

    Published in Mayo Clinic proceedings (01-03-2021)
    “…Multiple system atrophy (MSA) is a neurodegenerative disorder primarily characterized by autonomic failure plus parkinsonism or cerebellar ataxia. The…”
    Get full text
    Journal Article
  17. 17

    Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature by Ahlskog, J. Eric, Muenter, Manfred D.

    Published in Movement disorders (01-05-2001)
    “…There is no clear consensus regarding the frequency (and hence, the risk), of dyskinesias or motor fluctuations during chronic levodopa therapy for Parkinson's…”
    Get full text
    Journal Article
  18. 18

    A genomic pathway approach to a complex disease: axon guidance and Parkinson disease by Lesnick, Timothy G, Papapetropoulos, Spiridon, Mash, Deborah C, Ffrench-Mullen, Jarlath, Shehadeh, Lina, de Andrade, Mariza, Henley, John R, Rocca, Walter A, Ahlskog, J Eric, Maraganore, Demetrius M

    Published in PLoS genetics (01-06-2007)
    “…While major inroads have been made in identifying the genetic causes of rare Mendelian disorders, little progress has been made in the discovery of common gene…”
    Get full text
    Journal Article
  19. 19

    Increased risk of parkinsonism in women who underwent oophorectomy before menopause by ROCCA, W. A, BOWER, J. H, MARAGANORE, D. M, AHLSKOG, J. E, GROSSARDT, . R, DE ANDRADE, M, MELTON, L. J

    Published in Neurology (15-01-2008)
    “…There is increasing laboratory evidence for a neuroprotective effect of estrogen on the nigrostriatal pathway; however, the epidemiologic evidence remains…”
    Get full text
    Journal Article
  20. 20